Global Continuous Glucose Monitoring Device Market 2011-2015


April 6, 2012
31 Pages - SKU: INF3861919
License type:
Table of Contents Search inside this report Related Reports Detailed Contents
SMBG Market in India 2013
5/2/2013 | published by: Netscribes (India) Pvt. Ltd.
SMBG equipments has witnessed strong growth over the last few years on account of large number of diabetics and increasing awareness towards SMBG. People are also becoming aware of the harmful effects of diabetes.
read more...
$850.00
Drugs of Abuse: An Analysis of the Point-of-Care Testing Market: US, Germany, Spain, Physician Offices, Emergency Rooms, Ambulatory Care Centers
5/1/2013 | published by: Venture Planning Group
This new 194-page report from Venture Planning Group contains 22 tables, and provides a comprehensive analysis of the POC drugs of abuse testing market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and  |  read more...
$3,850.00
Retail Clinics: Consumer Attitudes Results of the 2013 Kalorama Survey
3/22/2013 | published by: Kalorama Information
Retail Clinics: Consumer Attitudes Results of the 2013 Kalorama Survey - Retail clinics are medical settings located in a retail store. They are not free standing and do not offer all medical services.  |  read more...
$995.00
2013 Analysis of the Point-of-Care Coagulation Testing Market: US, Germany, Spain Physician Offices, Emergency Rooms, Operating Suites, ICUs/CUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers
4/23/2013 | published by: Venture Planning Group
This new 450-page report from Venture Planning Group contains 53 tables, and provides a comprehensive analysis of the POC coagulation testing market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging  |  read more...
$7,500.00
2013 Analysis of the Point-of-Care Infectious Disease Diagnostics Market: US, Germany, Spain Physician Offices/Group Practices, Emergency Rooms, Ambulatory Care Centers, Surgery Centers, Birth Centers
4/29/2013 | published by: Venture Planning Group
This new 835-page report from Venture Planning Group contains 80 tables, and provides a comprehensive analysis of thePOC infectious disease testing market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging  |  read more...
$8,500.00
2013 Analysis of the PT and APTT Point-of-Care Testing Market: US, Germany, Spain,-Physician Offices, Emergency Rooms, Operating Suites, ICIs/CUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers
4/29/2013 | published by: Venture Planning Group
This new 366-page report from Venture Planning Group contains 39 tables, and provides a comprehensive analysis of the PT and APTT testing in POC locations, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive  |  read more...
$4,500.00
North America Injectable Drug Delivery Market – by Formulations [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables & Reusable, Fillable & Prefilled, Pen, Needle Free & Auto Injectors] & Therapeutics [Diabetes & Oncology] – Forecasts to 2017
4/8/2013 | published by: MarketsandMarkets
The North American injectable drug delivery technologies market was valued at $9.3 billion in 2012; it is expected to reach $16.6 billion by 2017 at a CAGR of 12.3% from 2012 to 2017. Injectable drug  |  read more...
$4,650.00
Diabetes – Pipeline Review, H1 2013
3/18/2013 | published by: Global Markets Direct
Diabetes – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Diabetes - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Diabetes, complete with latest  |  read more...
$2,000.00
Hemoglobin A1c Testing Markets
3/1/2013 | published by: TriMark Publications
Hemoglobin A1c (HbA1c) testing is the most recent major technology to have entered the diabetes testing market. As the global prevalence of diabetes mellitus continues to increase rapidly, with more than 366 million diabetics worldwide,  |  read more...
$3,400.00
Diabetic Nephropathy – Pipeline Review, H1 2013
3/18/2013 | published by: Global Markets Direct
Diabetic Nephropathy – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Diabetic Nephropathy - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Diabetic Nephropathy,  |  read more...
$2,000.00
 
Research assistance
We can help you find what you need. Call us or write us:
US: 800.298.5699
Int'l: +1.240.747.3093
Need help in your search?
 
Related Markets

Diabetes Reports
 
 

Share this report


Other tasks

 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!